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Diabetic mastopathy – an unusual differential diagnosis:
a case report*
Mastopatia diabética – um inusitado diagnóstico diferencial: relato de caso
Simone Elias1, Marina Celli Francisco2, Cláudio Kemp3, Beatriz Daou Verenhitach4,
Fabiano Celli Francisco5, Maria del Carmen M. Wolgien4
Diabetic mastopathy affects premenopausal women with longstanding type 1 diabetes mellitus. The diagnosis
is based on clinical findings (uni or bilateral hardened, palpable mass) associated with radiological (increase
in breast density), sonographic (marked posterior acoustic shadowing), and histopathological (fibrosis and
perivascular and periductal lymphocytic infiltration) findings. This disease may clinically simulate a breast
carcinoma. The case of a patient with diabetic mastopathy is reported.
Keywords: Diabetic mastopathy; Diabetes mellitus; Breast benign disease.
A mastopatia diabética acomete mulheres na pré-menopausa com diabetes mellitus tipo 1 de longa data.
Seu diagnóstico é feito associando achados clínicos (espessamento ou nódulo mamário endurecidos, uni ou
bilateral), radiológicos (aumento da densidade mamária), ultra-sonográficos (acentuada sombra acústica pos-
terior) e histopatológicos (fibrose e infiltrado linfocítico perivascular e periductal). Pode simular carcinoma.
Neste artigo relata-se um caso de paciente com mastopatia diabética.
Unitermos: Mastopatia diabética; Diabetes mellitus; Doença benigna da mama.
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demonstrated a markedly hypoechoic
nodular image and posterior acoustic shad-
owing, with 2.0 cm in diameter (Figure 2).
Initially, the patient was submitted to
fine-needle aspiration biopsy that resulted
inconclusive (smear presenting rare, non-
atypical epithelial cells). Considering the
unsatisfactory result, ultrasound-guided
core biopsy was performed. The anatomo-
pathological study demonstrated breast fi-
brosis with perivascular infiltrate compat-
ible with lymphocytic mastitis (Figure 3).
DISCUSSION
Diabetic mastopathy was firstly de-
scribed by Soler & Khardori(2), in a study
with 12 patients with breast fibrosis, thy-
roiditis and hand arthropathy associated
with type 1 diabetes mellitus. Estimated
prevalence of this disease is 1:1694 dia-
betic women(1). The presence of the disease
is also described in men(4).
A review of 120 cases of diabetic mas-
topathy has demonstrated that long-stand-
ing type 1 diabetes mellitus (approximately
20 years) was present in 115 of these 120
patients (with ages ranging between 25 and
40 years; the oldest patient was 64 years
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Khardori, as a benign disease clinically
simulating a breast carcinoma(2).
Its pathogenesis is still to be completely
known, but it is believed that this condition
develops as an autoimmune reaction in-
duced by the hyperglycemia, which would
result in an increased production of col-
lagen(1), with consequential lymphocytic
infiltrate with B lymphocytes against the
final products of the abnormal extracellu-
lar matrix glycosylation(3).
CASE REPORT
A female 35-year-old patient complain-
ing of a lump found during self-examina-
tion, at the intersection of the lateral quad-
rants of her right breast, near the retroareo-
lar region. Insulin-dependent, diabetic (dia-
betes mellitus) patient since she was 16
years old, reported inappropriate glycemia
management because of inadequate diet
and lack of regular physical activity.
At clinical examination, the patient pre-
sented with a 4.0 cm region of thickened
skin on her right breast. Mammography
demonstrated a partial fat-replaced pattern
with no lesion, even in the palpable area
(Figure 1). The sonographic evaluation
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INTRODUCTION
Breast is not classically included among
organs affected by diabetic complications;
however, a pathological manifestation de-
fined as diabetic mastopathy may rarely
occur (less than 1% of benign diseases)(1),
affecting up to 13% of patients with diabe-
tes mellitus type I, at some moment in the
course of the disease. Diabetic mastopathy
was firstly described in 1984 by Soler &
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old), with almost always multiple breast
lesions with sizes ranging from 5 mm to 6
cm in diameter(5).
Clinical feature is characterized by a
painless, ill-defined, movable breast lump,
without skin thickening or retraction. The
clinical feature corresponds to painless, ill-
defined, movable and hardened breast
mass, without skin thickening or retraction.
Unilateral or bilateral, multiple or non-pal-
pable masses may be observed(1). Sixty-
three per cent of the lesions are bilateral and
multiple. Considering the recidivation rate
of 80%, the knowledge of these character-
istics could avoid unnecessary biopsies(6).
Mammography may demonstrate an
area of increased density (focal asymme-
try). Venta et al.(7) have described mammo-
graphic images showing lobulated masses
in 52% of cases, oval-shaped masses in
50%, and round masses in 18% of cases.
On the other hand, ultrasound may demon-
strate irregular, hypoechoic masses with
marked posterior acoustic shadowing,
where the main differential diagnosis is
breast carcinoma(1).
Few studies in the literature report the
utilization of magnetic resonance imaging
in these patients. Most recently, spectros-
copy has been proposed as a method for
confirming the lesions benignity, demon-
strating the presence or absence of a cho-
line peak areas, with sensitivity and speci-
ficity ranging between 82% and 100%(8).
A histological diagnosis is essential in
cases of clinically and radiologically sus-
pected diabetic mastopathy. Some authors
have proposed the diagnosis by aspiration
biopsy, but this method is successful in less
than 50% of cases because of the hardness
and poor cellularity of the lesions. There-
fore, histological biopsies, particularly core
biopsy is considered as the most appropri-
ate method for obtaining a definite diagno-
sis(1).
CONCLUSION
The knowledge of clinical and imaging
manifestations of diabetic mastopathy al-
lows the appropriate diagnosis of this dis-
ease, whose main differential diagnosis is
breast carcinoma.
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Figure 1. Bilateral mammography
with no abnormalities. The palpable
area (intersection of the right breast
lateral quadrants, adjacent to the
retroareolar region) is normal.
Figure 2. Markedly hypoechoic, ill-
defined lesion, with posterior
acoustic shadowing, measuring 2.0
cm in diameter, at the intersection
of right breast lateral quadrants.
Figure 1 Figure 2
Figure 3. Diffuse sclerosis
(stroma expansion), where the
presence of enlarged fibroblasts
with ovoid nuclei and abundant
cytoplasms can be observed (a).
Note perivascular and pericana-
licular lymphocytic collections
(b). Absence of malignancy.
